Transplantation oxygen therapeutics. Evidence in context.
Two evidence layers are kept deliberately separate: the historical/direct oxygen-carrier catalogue and external transplantation science that is relevant to future BHOC oxygen-delivery research.
Layer 1 · Historical / direct oxygen-carrier evidence
HBOC, HBOC-201 & Hemopure evidence
Source-linked transplantation records that directly discuss historical oxygen carriers, HBOC-201, Hemopure or closely related oxygen-carrier perfusion work.
This layer retains the terminology and evidence class of the original sources.
Layer 2 · Scientific evidence relevant to BHOC
Transplant oxygen-delivery research environment
External studies on preservation, machine perfusion, regional perfusion, viability assessment and ischemia-reperfusion that help define testable BHOC research questions.
Counts represent catalogue records assigned to one primary transplant direction. They describe the evidence map, not regulatory approvals or clinical recommendations.
How to interpret these numbers
The catalogue contains clinical, preclinical, analytical and review records. Evidence type and original identifiers should be read at publication level. A source link confirms traceability, not the strength or outcome of a study.
Records without a confirmed original identifier remain in the catalogue for further review and are not presented as validated clinical claims.
The transplant pathway
Oxygen delivery across the graft journey.
Transplant oxygen-therapeutic research spans more than one intervention point. The catalogue follows evidence from preservation and machine perfusion through viability assessment and reperfusion.
01Preservation
02Machine perfusion
03Viability assessment
04Reperfusion
The evidence hub preserves historical HBOC, HBOC-201 and Hemopure terminology used by source publications while connecting it to BHOC - Biological Hemoglobin Oxygen Carrier - and Precision Oxygenation Therapeutics.
Scientific Evidence Relevant to BHOC & Transplant Oxygen Delivery
The unified BHOC evidence catalogue now covers liver, kidney and lung transplantation without mixing these papers into the historical HBOC / Hemopure catalogue.
This section is a structured evidence map. Publication inclusion does not establish efficacy, regulatory approval or a clinical recommendation. Historical product names are retained for accurate scientific discovery.